The Wall Street Journal: How the Kodak generic-drug ingredients deal developed, and why it fell apart: a snapshot

The Wall Street Journal: How the Kodak generic-drug ingredients deal developed, and why it fell apart: a snapshot

20 Aug    Finance News

On a white board in his office earlier this year, Trump trade adviser Peter Navarro made a list of potential companies that could manufacture pharmaceuticals in the U.S.

He separated them into three columns, one for each stage of the production process. Eastman Kodak Co. stood out, overlapping two of the three columns. The way Navarro saw it, he recalled, Kodak could help produce the ingredients to jump-start generic drug production and ease the country’s reliance on foreign supplies.

See also  The Chicken Sandwich Wars aren't over #food

Leave a Reply

Your email address will not be published. Required fields are marked *